AltheaDx: Bringing Theranostics into Clinical Use

Discovery to Diagnostics Pathway

	Broad RNA expression profiling using Affymetrix® Microarrays: Reliably and reproducibly identifies critical gene sets
	Quantification via proprietary multiplexed XP-PCR: Sensitive, cost-effective measurement of biomarker gene panels
	"Blood to Blocks": Capable of analyzing a wide range of samples including blood, fresh frozen and FFPE tissues
	RNA-QC Assays to pre-qualify samples
	DNA genotyping: Identifies key mutations and SNPs
	Custom data analysis and expertise in all phases of cancer diagnostic development

	Diagnosis/prognosis of prostate cancer
	Diagnosis of childhood cancer
	Custom gene panels for targeted oncology therapeutics
	AltheaDx is your partner for discovery, development and regulatory submission of new biomarkers for diagnosis and prognosis of disease.